Article Text

Download PDFPDF
Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn’s disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A K Akobeng

Dr A K Akobeng, Booth Hall Children’s Hospital, Manchester, UK;


Which interventions are effective for maintaining remission in Crohn’s disease?


Included studies evaluated interventions for maintaining remission in Crohn’s disease. Outcome was maintenance of remission (or relapse).


Medline (1966 to May 2007), Cochrane Library (Issue 2, 2007), and Cochrane Inflammatory Bowel Disease Group were searched for randomised controlled trials (RCTs) or systematic reviews or meta-analyses of RCTs. 8 interventions (azathioprine, 5-aminosalicylates, corticosteroids, budesonide, antimycobacterial agents, probiotics, omega-3 fatty acids, and enteral nutrition) were evaluated in systematic reviews, and 6 interventions (methotrexate, infliximab, adalimumab, natalizumab, certolizumab, and ciclosporin) were evaluated in RCTs. …

View Full Text


  • Source of funding: no external funding.